Table 5. Measures for estimation of synergic effect between tumor size and N stage for the risk of distant metastasis in DTC.
Tumor size | N stage | M1 case (%) | Total case | Odds ratio (95% CI) | P value |
---|---|---|---|---|---|
<10 mm | 0 | 71 (0.3) | 28,048 | Reference | |
1 | 53 (1.6) | 3,274 | 7.807 (4.978–12.242) | <0.001* | |
≥10 mm | 0 | 393 (0.9) | 43,168 | 4.979 (3.553–6.978) | <0.001* |
1 | 579 (3.5) | 16,689 | 13.584 (9.617–19.189) | <0.001* | |
RERI | 5.058 (2.713–7.403) | ||||
AP | 0.357 (0.219–0.496) | ||||
SI | 1.624 (1.275–2.069) |
Adjusted for age at diagnosis, sex, race, histology subtype, extrathyroidal extension. *, represent the P value <0.05. DTC, differentiated thyroid cancer; CI, confidence interval; RERI, relative excess risk; AP, attributable proportion; SI, synergy index.